Improved Management of Patients With Recent-Onset Stable Chest Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30+
SponsorPhilipps University Marburg

About this trial

In Germany, coronary CT offers an accurate and less burdensome alternative to cardiac catheterisation for evaluating suspected coronary artery disease, but it is still underused. The IMPRO stepped-wedge trial tests a new, nationwide care model (NVF) in 16 regions to improve guideline-based intersectoral implementation of coronary CT and assess its impact on cardiovascular outcomes and healthcare costs. If effective, the model of care (NVF) could be adopted across Germany to enhance care quality while reducing unnecessary procedures and expenses.

Eligibility criteria

Qualifiers

Age ≥30 years

Suspected CAD with stable chest pain

Ability to give informed consent

Disqualifiers

Known or previously treated (with PCI or CABG) obstructive CAD (defined as at least one coronary diameter stenosis ≥50%)

Acute coronary syndrome

Negative invasive coronary angiography or coronary CT within the last 5 years

Already enrolled in the study

Trial design

Treatments tested in this trial

  • IMPRO - Cross-Sectoral Care Model for Coronary Diagnostics

Treatment groups

3,369 Participants
are divided into 2 treatment groups

Locations

39
Universitätsklinikum Augsburg, Diagnostische und Interventionelle Radiologie und Neuroradiologie86156, Augsburg Germany
Universitätsklinikum Augsburg, Institut für Allgemeinmedizin86156, Augsburg Germany
RHOEN-Klinikum AG, Campus Bad Neustadt, Klinik für Radiologie97616, Bad Neustadt an der Saale Germany
Charité - Universitätsmedizin Berlin, Klinik für Radiologie10117, Berlin Germany

Sponsors and collaborators

Philipps University Marburg

Lead sponsor

Gemeinsamer Bundesaussschuss

Collaborator